These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 7543572)
21. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity. Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634 [TBL] [Abstract][Full Text] [Related]
22. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat. Mijnster MJ; Schotte A; Docter GJ; Voorn P Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839 [TBL] [Abstract][Full Text] [Related]
23. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296 [TBL] [Abstract][Full Text] [Related]
24. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain. Kinkead B; Shahid S; Owens MJ; Nemeroff CB J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962 [TBL] [Abstract][Full Text] [Related]
25. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184 [TBL] [Abstract][Full Text] [Related]
26. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment. Janicki P; Lypko A; Szczudlik A; Libich J Pol J Pharmacol Pharm; 1981; 33(5):499-502. PubMed ID: 6174959 [TBL] [Abstract][Full Text] [Related]
27. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain. Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740 [TBL] [Abstract][Full Text] [Related]
28. Ontogeny of the effect of antipsychotic drug treatment on neurotensin concentrations in the rat brain. Kinkead B; Owens MJ; Nemeroff CB Synapse; 1995 Jul; 20(3):244-8. PubMed ID: 7570356 [TBL] [Abstract][Full Text] [Related]
29. Sensitization to amphetamine occurs simultaneously at immune level and in met-enkephalin of the nucleus accumbens and spleen: an involved NMDA glutamatergic mechanism. Assis MA; Hansen C; Lux-Lantos V; Cancela LM Brain Behav Immun; 2009 May; 23(4):464-73. PubMed ID: 19486656 [TBL] [Abstract][Full Text] [Related]
30. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment. Dawson NM; Hamid EH; Egan MF; Meredith GE Synapse; 2001 Jan; 39(1):70-81. PubMed ID: 11071712 [TBL] [Abstract][Full Text] [Related]
31. Striatal neuropeptide levels in Parkinson's disease patients. Fernandez A; de Ceballos ML; Jenner P; Marsden CD Neurosci Lett; 1992 Oct; 145(2):171-4. PubMed ID: 1281532 [TBL] [Abstract][Full Text] [Related]
32. Brain neuropeptides in progressive supranuclear palsy. Taquet H; Javoy-Agid F; Mauborgne A; Benoliel JJ; Agid Y; Legrand JC; Hamon M; Cesselin F Brain Res; 1987 May; 411(1):178-82. PubMed ID: 2440513 [TBL] [Abstract][Full Text] [Related]
33. Effect of dopaminergic drugs on processing and degradative neuropeptidase mRNA in rat frontal cortex and caudate-putamen. Waters SM; Rounseville MP; Davis TP Brain Res; 1997 Apr; 754(1-2):28-34. PubMed ID: 9134956 [TBL] [Abstract][Full Text] [Related]
34. Subcutaneous formalin enhances outflow of met-enkephalin- and cholecystokinin-like materials in the rat nucleus accumbens. Lapeyre S; Mauborgne A; Becker C; Benoliel JJ; Cesselin F; Hamon M; Bourgoin S Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):399-406. PubMed ID: 11330333 [TBL] [Abstract][Full Text] [Related]
35. Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model. Kawada Y; Ogawa N; Asanuma M; Mori A Regul Pept; 1995 Jan; 55(1):103-10. PubMed ID: 7536949 [TBL] [Abstract][Full Text] [Related]
36. Subchronic haloperidol administration decreases aminopeptidase N activity and [Met5]enkephalin metabolism in rat striatum and cortex. Konkoy CS; Waters SM; Davis TP Eur J Pharmacol; 1996 Feb; 297(1-2):47-51. PubMed ID: 8851165 [TBL] [Abstract][Full Text] [Related]
38. Chronic exposure to hypergravity affects thyrotropin-releasing hormone levels in rat brainstem and cerebellum. Daunton NG; Tang F; Corcoran ML; Fox RA; Man SY Biol Signals Recept; 1998; 7(6):337-44. PubMed ID: 9873155 [TBL] [Abstract][Full Text] [Related]
39. Comparison between short- and long-term haloperidol administration on somatostatin and substance P concentrations in the rat brain. Radke JM; MacLennan AJ; Vincent SR; Fibiger HC Brain Res; 1988 Mar; 445(1):55-60. PubMed ID: 2452671 [TBL] [Abstract][Full Text] [Related]
40. Effects of short- and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat. Radke JM; MacLennan AJ; Beinfeld MC; Bissette G; Nemeroff CB; Vincent SR; Fibiger HC Brain Res; 1989 Feb; 480(1-2):178-83. PubMed ID: 2713650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]